Catalyst Wire Dossier Catalyst Wire Dossier

Medtronic NMX8 Automated Insulin Delivery System

· Medtronic MiniMed, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Medtronic NMX8 Automated Insulin Delivery System, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes [NA]

See pricing